Literature DB >> 8024009

Impaired nitric oxide-dependent responses and their recovery in hypertensive pulmonary arteries of rats.

J Maruyama1, K Maruyama.   

Abstract

To study the changes of endothelium-dependent and -independent relaxation in structurally remodeled pulmonary arteries with hypoxic pulmonary hypertension and their reversibility during recovery in room air, rats were exposed to hypobaric hypoxia (air at 380 mmHg) for 10 days and then allowed to recover in room air for 3, 14, 28, or 56 days. Relaxation by acetylcholine, sodium nitroprusside (SNP), and isoproterenol was depressed in large- and small-conduit pulmonary arterial rings from rats exposed to 10 days of hypoxia. The relaxant response to isoproterenol and SNP was normalized completely after 3 and 28 days of recovery, respectively. The relaxation by acetylcholine was still impaired at high concentrations after 56 days. A cyclooxygenase inhibitor, indomethacin, enhanced relaxation by acetylcholine of rings from experimental rats but not from control rats. Endothelium-denuded rings showed no difference in the response to acetylcholine between control and experimental rats. In conclusion, the impaired response to acetylcholine may be related to acetylcholine-induced, cyclooxygenase-dependent production of a vasoconstrictor by endothelial cells and to depressed smooth muscle response to nitric oxide (NO). During recovery, the NO-induced guanosine 3',5'-cyclic monophosphate-dependent dilation returned to normal. However, the release of cyclooxygenase-dependent production of a vasoconstrictor may persist even after 56 days of recovery.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8024009     DOI: 10.1152/ajpheart.1994.266.6.H2476

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  10 in total

1.  Sarpogrelate hydrochloride, a serotonin 5HT2A receptor antagonist, ameliorates the development of chronic hypoxic pulmonary hypertension in rats.

Authors:  Erquan Zhang; Junko Maruyama; Ayumu Yokochi; Yoshihide Mitani; Hirofumi Sawada; Masakatsu Nishikawa; Ning Ma; Kazuo Maruyama
Journal:  J Anesth       Date:  2015-05-01       Impact factor: 2.078

2.  Role of NO in recovery from neonatal hypoxic pulmonary hypertension.

Authors:  R M Tulloh; A A Hislop; S G Haworth
Journal:  Thorax       Date:  1999-09       Impact factor: 9.139

Review 3.  The structural basis of pulmonary hypertension in chronic lung disease: remodelling, rarefaction or angiogenesis?

Authors:  Natalie Hopkins; Paul McLoughlin
Journal:  J Anat       Date:  2002-10       Impact factor: 2.610

4.  Colforsin-induced vasodilation in chronic hypoxic pulmonary hypertension in rats.

Authors:  Ayumu Yokochi; Hiroo Itoh; Junko Maruyama; Erquan Zhang; Baohua Jiang; Yoshihide Mitani; Chikuma Hamada; Kazuo Maruyama
Journal:  J Anesth       Date:  2010-03-19       Impact factor: 2.078

5.  Changes in functional and histological distributions of nitric oxide synthase caused by chronic hypoxia in rat small pulmonary arteries.

Authors:  Mikiyasu Shirai; James T Pearson; Akito Shimouchi; Noritoshi Nagaya; Hirotsugu Tsuchimochi; Ishio Ninomiya; Hidezo Mori
Journal:  Br J Pharmacol       Date:  2003-07       Impact factor: 8.739

Review 6.  Novel approaches to treat experimental pulmonary arterial hypertension: a review.

Authors:  S Umar; P Steendijk; D L Ypey; D E Atsma; E E van der Wall; M J Schalij; A van der Laarse
Journal:  J Biomed Biotechnol       Date:  2010-03-22

7.  Endothelium-dependent relaxations in sheep pulmonary arteries and veins: resistance to block by NG-nitro-L-arginine in pulmonary hypertension.

Authors:  B K Kemp; J J Smolich; B C Ritchie; T M Cocks
Journal:  Br J Pharmacol       Date:  1995-11       Impact factor: 8.739

8.  Nitric Oxide-Dependent Feedback Loop Regulates Transient Receptor Potential Vanilloid 4 (TRPV4) Channel Cooperativity and Endothelial Function in Small Pulmonary Arteries.

Authors:  Corina Marziano; Kwangseok Hong; Eric L Cope; Michael I Kotlikoff; Brant E Isakson; Swapnil K Sonkusare
Journal:  J Am Heart Assoc       Date:  2017-12-23       Impact factor: 5.501

9.  Model difference in the effect of cilostazol on the development of experimental pulmonary hypertension in rats.

Authors:  Toshikazu Ito; Erquan Zhang; Ayaka Omori; Jane Kabwe; Masako Kawai; Junko Maruyama; Amphone Okada; Ayumu Yokochi; Hirofumi Sawada; Yoshihide Mitani; Kazuo Maruyama
Journal:  BMC Pulm Med       Date:  2021-11-20       Impact factor: 3.317

10.  CRISPR-mediated Bmpr2 point mutation exacerbates late pulmonary vasculopathy and reduces survival in rats with experimental pulmonary hypertension.

Authors:  Jane Chanda Kabwe; Hirofumi Sawada; Yoshihide Mitani; Hironori Oshita; Naoki Tsuboya; Erquan Zhang; Junko Maruyama; Yoshiki Miyasaka; Hideyoshi Ko; Kazunobu Oya; Hiromasa Ito; Noriko Yodoya; Shoichiro Otsuki; Hiroyuki Ohashi; Ryuji Okamoto; Kaoru Dohi; Yuhei Nishimura; Tomoji Mashimo; Masahiro Hirayama; Kazuo Maruyama
Journal:  Respir Res       Date:  2022-04-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.